Search Results - Pivot, Xavier

Refine Results
  1. 1
    Can we establish a hierarchy among trastuzumab biosimilar candidates?

    Can we establish a hierarchy among trastuzumab biosimilar candidates? by Pivot, Xavier, Petit, Thierry

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  2. 2
    Subgroup analysis of patients with HER2-negative metastatic breast cancer in the second-line setting from a phase 3, open-label, randomized study of eribulin mesilate versus capecitabine

    Subgroup analysis of patients with HER2-negative metastatic breast cancer in the second-line setting from a phase 3, open-label, randomized study of eribulin mesilate versus capeci... by Pivot, Xavier, Im, Seock Ah, Guo, Matthew, Marmé, Frederik

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  3. 3
    Adjuvant Trastuzumab Is Required in Human Epidermal Growth Factor Receptor 2-Positive Node-Negative Breast Cancer Patients Regardless of Tumour Size

    Adjuvant Trastuzumab Is Required in Human Epidermal Growth Factor Receptor 2-Positive Node-Negative Breast Cancer Patients Regardless of Tumour Size by Bender, Laura, Kurtz, Jean-Emmanuel, Petit, Thierry, Pivot, Xavier

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  4. 4
    Biologic Drug Quality Assurance to Optimize HER2 + Breast Cancer Treatment: Insights from Development of the Trastuzumab Biosimilar SB3

    Biologic Drug Quality Assurance to Optimize HER2 + Breast Cancer Treatment: Insights from Development of the Trastuzumab Biosimilar SB3 by Lüftner, Diana, Lyman, Gary H., Gonçalves, João, Pivot, Xavier, Seo, Minji

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  5. 5
    Correction to: Biologic Drug Quality Assurance to Optimize HER2+ Breast Cancer Treatment: Insights from Development of the Trastuzumab Biosimilar SB3

    Correction to: Biologic Drug Quality Assurance to Optimize HER2+ Breast Cancer Treatment: Insights from Development of the Trastuzumab Biosimilar SB3 by Lüftner, Diana, Lyman, Gary H., Gonçalves, João, Pivot, Xavier, Seo, Minji

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  6. 6
    Evaluating the clinical effectiveness and safety of various HER2-targeted regimens after prior taxane/trastuzumab in patients with previously treated, unresectable, or metastatic HER2-positive breast cancer: a systematic review and network meta-analysis

    Evaluating the clinical effectiveness and safety of various HER2-targeted regimens after prior taxane/trastuzumab in patients with previously treated, unresectable, or metastatic H... by Paracha, Noman, Reyes, Adriana, Diéras, Véronique, Krop, Ian, Pivot, Xavier, Urruticoechea, Ander

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  7. 7
    MAINTENANCE HORMONAL TREATMENT IMPROVES PROGRESSION FREE SURVIVAL AFTER A FIRST LINE CHEMOTHERAPY IN PATIENTS WITH METASTATIC BREAST CANCER

    MAINTENANCE HORMONAL TREATMENT IMPROVES PROGRESSION FREE SURVIVAL AFTER A FIRST LINE CHEMOTHERAPY IN PATIENTS WITH METASTATIC BREAST CANCER by Dufresne, Armelle, Pivot, Xavier, Tournigand, Christophe, Facchini, Thomas, Alweeg, Thierry, Chaigneau, Loic, De Gramont, Aimery

    Published 2008
    Get full text Get full text
    Text
    Save to List
    Saved in:
  8. 8
    Organizing medical oncology care at a regional level and its subsequent impact on the quality of early breast cancer management: a before-after study

    Organizing medical oncology care at a regional level and its subsequent impact on the quality of early breast cancer management: a before-after study by Voidey, Aline, Pivot, Xavier, Woronoff, Anne-Sophie, Nallet, Gilles, Cals, Laurent, Schwetterle, Francis, Limat, Samuel

    Published 2014
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  9. 9
    A time and motion study of subcutaneous versus intravenous trastuzumab in patients with HER2‐positive early breast cancer

    A time and motion study of subcutaneous versus intravenous trastuzumab in patients with HER2‐positive early breast cancer by De Cock, Erwin, Pivot, Xavier, Hauser, Nik, Verma, Sunil, Kritikou, Persefoni, Millar, Douglas, Knoop, Ann

    Published 2016
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  10. 10
    A phenotypic and mechanistic perspective on heterogeneity of HER2-positive breast cancers

    A phenotypic and mechanistic perspective on heterogeneity of HER2-positive breast cancers by Ferrari, Anthony, Sertier, Anne-Sophie, Vincent-Salomon, Anne, Pivot, Xavier, Pauporté, Iris, Saintigny, Pierre, Birnbaum, Daniel, Viari, Alain

    Published 2016
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  11. 11
    Intra-operative intra-peritoneal chemotherapy with cisplatin in patients with peritoneal carcinomatosis of ovarian cancer

    Intra-operative intra-peritoneal chemotherapy with cisplatin in patients with peritoneal carcinomatosis of ovarian cancer by Guardiola, Emmanuel, Delroeux, Delphine, Heyd, Bruno, Combe, Marielle, Lorgis, Veronique, Demarchi, Martin, Stein, Ulrich, Royer, Bernard, Chauffert, Bruno, Pivot, Xavier

    Published 2009
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  12. 12
    A phase 2 randomized trial to evaluate the impact of a supervised exercise program on cardiotoxicity at 3 months in patients with HER2 overexpressing breast cancer undergoing adjuvant treatment by trastuzumab: design of the CARDAPAC study

    A phase 2 randomized trial to evaluate the impact of a supervised exercise program on cardiotoxicity at 3 months in patients with HER2 overexpressing breast cancer undergoing adjuv... by Jacquinot, Quentin, Meneveau, Nathalie, Chatot, Marion, Bonnetain, Franck, Degano, Bruno, Bouhaddi, Malika, Dumoulin, Gilles, Vernerey, Dewi, Pivot, Xavier, Mougin, Fabienne

    Published 2017
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  13. 13
    Real-world patient-reported outcomes of women receiving initial endocrine-based therapy for HR+/HER2− advanced breast cancer in five European countries

    Real-world patient-reported outcomes of women receiving initial endocrine-based therapy for HR+/HER2− advanced breast cancer in five European countries by Davie, Alison, Carter, Gebra Cuyun, Rider, Alex, Pike, James, Lewis, Katie, Bailey, Abigail, Price, Gregory L., Ringeisen, Francois, Pivot, Xavier

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  14. 14
    Safety and Efficacy of Cabazitaxel in the Docetaxel-Treated Patients with Hormone-Refractory Prostate Cancer

    Safety and Efficacy of Cabazitaxel in the Docetaxel-Treated Patients with Hormone-Refractory Prostate Cancer by Calcagno, Fabien, Nguyen, Thierry, Dobi, Erion, Villanueva, Cristian, Curtit, Elsa, Kim, Stefano, Montcuquet, Philippe, Kleinclauss, François, Pivot, Xavier, Thiery-Vuillemin, Antoine

    Published 2012
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  15. 15
    Cisplatin/gemcitabine or oxaliplatin/gemcitabine in the treatment of advanced biliary tract cancer: a systematic review

    Cisplatin/gemcitabine or oxaliplatin/gemcitabine in the treatment of advanced biliary tract cancer: a systematic review by Fiteni, Frédéric, Nguyen, Thierry, Vernerey, Dewi, Paillard, Marie-Justine, Kim, Stefano, Demarchi, Martin, Fein, Francine, Borg, Christophe, Bonnetain, Franck, Pivot, Xavier

    Published 2014
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  16. 16
    Subcutaneous vs Intravenous Trastuzumab for Patients With ERBB2-Positive Early Breast Cancer: Final Analysis of the HannaH Phase 3 Randomized Clinical Trial

    Subcutaneous vs Intravenous Trastuzumab for Patients With ERBB2-Positive Early Breast Cancer: Final Analysis of the HannaH Phase 3 Randomized Clinical Trial by Jackisch, Christian, Stroyakovskiy, Daniil, Pivot, Xavier, Ahn, Jin Seok, Melichar, Bohuslav, Chen, Shin-Cheh, Meyenberg, Christoph, Al-Sakaff, Nedal, Heinzmann, Dominik, Hegg, Roberto

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  17. 17
    Beliefs and behavior regarding e-cigarettes in a large cross-sectional survey

    Beliefs and behavior regarding e-cigarettes in a large cross-sectional survey by Couraud, Sébastien, Cortot, Alexis B., Pivot, Xavier B., Touboul, Chantal, Lhomel, Christine, Blay, Jean-Yves, Eisinger, François, Viguier, Jérôme, Morère, Jean-François, Greillier, Laurent

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  18. 18
    Adjuvant Subcutaneous Trastuzumab for HER2‐Positive Early Breast Cancer: Subgroup Analyses of Safety and Active Medical Conditions by Body Weight in the SafeHer Phase III Study

    Adjuvant Subcutaneous Trastuzumab for HER2‐Positive Early Breast Cancer: Subgroup Analyses of Safety and Active Medical Conditions by Body Weight in the SafeHer Phase III Study by Jung, Kyung Hae, Ataseven, Beyhan, Verrill, Mark, Pivot, Xavier, De Laurentiis, Michelino, Al‐Sakaff, Nedal, Lauer, Sabine, Shing, Mona, Gligorov, Joseph, Azim, Hamdy A.

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  19. 19
    Dendritic cell and natural killer cell cross-talk: a pivotal role of CX3CL1 in NK cytoskeleton organization and activation

    Dendritic cell and natural killer cell cross-talk: a pivotal role of CX3CL1 in NK cytoskeleton organization and activation by Pallandre, Jean R., Krzewski, Konrad, Bedel, Romain, Ryffel, Bernhard, Caignard, Anne, Rohrlich, Pierre Simon, Pivot, Xavier, Tiberghien, Pierre, Zitvogel, Laurence, Strominger, Jack L., Borg, Christophe

    Published 2008
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  20. 20
    Efficacy of trabectedin in metastatic solitary fibrous tumor

    Efficacy of trabectedin in metastatic solitary fibrous tumor by Chaigneau, Loïc, Kalbacher, Elsa, Thiery-Vuillemin, Antoine, Fagnoni-Legat, Christine, Isambert, Nicolas, Aherfi, Lionel, Pauchot, Julien, Delroeux, Delphine, Servagi-Vernat, Stephanie, Mansi, Laura, Pivot, Xavier

    Published 2011
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:

Search Tools: